Subcutaneous and Intravenous Daratumumab Have Similar Safety, Efficacy in Previously Treated and Newly Diagnosed Myeloma

Press/Media

Period	1 Nov 2019

Media coverage

Title	Subcutaneous and Intravenous Daratumumab Have Similar Safety, Efficacy in Previously Treated and Newly Diagnosed Myeloma
Media name/outlet	ASH Clinical News
Country/Territory	United States
Date	1/11/19
URL	https://www.ashclinicalnews.org/on-location/other-meetings/subcutaneous-intravenous-daratumumab-similar-safety-efficacy-previously-treated-newly-diagnosed-myeloma/
Persons	Ajai Chari